Trials / Completed
CompletedNCT05288582
Tear Lipid Layer Thickness Assessments With Perfluorohexyloctane Eye Drops
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Ohio State University · Academic / Other
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to explore the tear lipid layer quantitatively and qualitatively before and after use of a perflurohexyloctane eye drop (NovaTears)
Detailed description
The tear lipid layer will be studied before and after the use of an over-the-counter eye drop (NovaTears, Novaliq GmbH, Heidelberg, Germany) using a Stroboscopic Video Color Microscope, which is non-invasive.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NovaTears | Over-the-counter eye drop |
Timeline
- Start date
- 2022-03-27
- Primary completion
- 2022-07-31
- Completion
- 2022-11-30
- First posted
- 2022-03-21
- Last updated
- 2023-02-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05288582. Inclusion in this directory is not an endorsement.